Evidence map›Paper›PMID 38872454›Full record

ArticleActa obstetricia et gynecologica Scandinavica2024

Genome sequencing differentiates a paracentric inversion from a balanced insertion enabling more accurate preimplantation genetic testing.

Josephine Wincent, Hafdís T Helgadóttir, Fotios Sergouniotis, Angelo Salazar Mantero, Claudia M B Carvalho, Helena Malmgren, Anna Lindstrand, Erik Iwarsson

Abstract readCase Reports
In one paragraph

Article in Acta obstetricia et gynecologica Scandinavica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Josephine WincentDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-1698-9605
Hafdís T HelgadóttirDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Fotios SergouniotisDepartment of Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden.
Angelo Salazar ManteroDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Claudia M B CarvalhoPacific Northwest Research Institute, Seattle, Washington, USA.
Helena MalmgrenDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Anna LindstrandDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Erik IwarssonDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-3827-0263

Funding

Uncovering inversion formation in the human genome and its impact to disease.R01GM132589 · NIGMS · PACIFIC NORTHWEST RESEARCH INSTITUTE · PI FONSECA, CLAUDIA CARVALHO · 2020 to 2024
$3.5M
Carl-Axel Rydbeck Donation 2023-00483Karolinska Institutet 2022-02124NIGMS NIH HHS R01 GM132589Region Stockholm FoUI-961392SällsyntafondenVetenskapsrådet 2019-02078
6 · The paper itself

Abstract

introductionDistinguishing paracentric inversions (PAIs) from chromosomal insertions has traditionally relied on fluorescent in situ hybridization (FISH) techniques, but recent advancements in high-throughput sequencing have enabled the use of genome sequencing for such differentiation. In this study, we present a 38-year-old male carrier of a paracentric inversion on chromosome 2q, inv (2)(q31.2q34), whose partner experienced recurrent miscarriages. MATERIAL AND

methodsFISH analysis confirmed the inversion, and genome sequencing was employed for detailed characterization.

resultsPreimplantation genetic testing (PGT) revealed that all assessed embryos were balanced, consistent with the low risk of unbalanced offspring associated with PAIs. While PAI carriers traditionally exhibit low risk of producing unbalanced offspring, exceptions exist due to crossover events within the inversion loop. Although the sample size was limited, the findings align with existing sperm study data, supporting the rare occurrence of unbalanced progeny in PAI carriers.

conclusionsThis study highlights the possibility of characterizing PAIs using genome sequencing to enable correct reproductive counseling and PGT decisions. Detailed characterization of a PAI is crucial for understanding potential outcomes and guiding PGT strategies, as accurate knowledge of the inversion size is essential for appropriate method selection in PGT. Given the very low risk of unbalanced offspring in PAI carriers, routine PGT may not be warranted but should be considered in specific cases with a history of unbalanced progeny or recurrent miscarriages. This study contributes to our understanding of PAI segregation and its implications for reproductive outcomes.

Indexed as

Chromosome InversionGenetic TestingMutagenesis, InsertionalPreimplantation DiagnosisWhole Genome SequencingAbortion, HabitualAdultChromosomes, Human, Pair 2FemaleHumansIn Situ Hybridization, FluorescenceMalePregnancygenetic diagnosticsgenome sequencinginv(2)paracentric inversionpreimplantation genetic testing

Identifiers

PMID38872454
PMCPMC11266630

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.